Hypertension Essentials 2010Hypertension affects hundreds of millions of individuals worldwide, including 60% of those over the age of 60. Proper treatment reduces by 30% the incidence and fatality from coronary heart disease, heart failure, stroke, and kidney disease. Hypertension Essentials 2010 is a current, concise, and practical step-by-step guide to the diagnosis, evaluation, and treatment of hypertension. More than 50 clinical trials, common management pitfalls, and cardiovascular risk reduction measures are also described. |
Other editions - View all
Common terms and phrases
ACE inhibitors adrenal aldosterone aliskiren all-cause mortality ALLHAT amlodipine angina angiotensin II angiotensin II receptor antihypertensive antihypertensive drugs antihypertensive therapy Applicability of data ARBs atenolol baseline benazepril blood pressure measurements calcium antagonist calcium channel blocker Carboxyl Yes Renal cardiac cardiovascular disease cardiovascular events cardiovascular risk factors Causes of Secondary CCBs chlorthalidone clinical trial coronary heart disease darusentan death diabetes Diagnosis diastolic diastolic blood pressure dose elderly eplerenone Evaluation fatal follow-up HCTZ heart failure hydrochlorothiazide hypertensive emergencies hypertensive patients hypokalemia increased initial therapy intake labetalol left ventricular Length of trial lifestyle modification lower blood pressure mg qd mmHg monotherapy nonfatal stroke Participants Patients were randomized peripheral placebo potassium Primary end points Pseudohypertension ramipril receptor blocker reduced regimen renal insufficiency renin Results Secondary end points Secondary Hypertension side effects sodium spironolactone systolic blood pressure Table target organ damage telmisartan thiazide Treatment Group Treatment of Hypertension valsartan vascular verapamil white-coat